Developing a novel therapy for chronic back pain. This project is funded by the @EU_H2020 research and innovation programme under grant agreement No° 825925
Utrecht, The Netherlands
Joined January 2019
- Tweets479
- Following558
- Followers413
- Likes372
Our #ipspine end of project newsletter is here! Dive deep into our journey, hear from coordinator @MTryfonidou, explore our latest publications, and more. Plus, read insights into our patient advisory board. Read it here -> ipspine.eu/ipspine-newslette…
🎁 After three successful days, our final #iPSpine consortium meeting concludes!
✅ We covered everything from stem cell development to regulatory frameworks.
🙏 A big thank you to our amazing iPSpine team and @UniUtrecht and @Catalyze_Group for hosting us in Utrecht!
🔦 Another insight!
👩🏫Zaklina Buljovcic and Angela Vogt-Eisele were at #iPSpine: a unique opportunity to have worked with @PharmaLexGLOBAL Cencora in guiding iPSpine during our regulatory journey of our 1st of class therapy in development.
🔎 Come have a look as @rosario_isasi presents at our final #iPSpine consortium meeting: regulations and policy - The backbone of our scientific work in our battle to change the landscape and push ATMP therapies forward!
❗Prof. Andras Nagy, Senior Investigator at Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital Joseph & Wolf Lebovic Health Complex, enlightened us on a Safe and immune-evasive Stem Cell Source for developing Off-the-Shelf Therapeutic Cell Products with his great talk!
🌟Last week, lower back pain patients, researchers, and medical professionals came together at the iPSpine Patient Symposium.
💡Patients shared their personal experiences and researchers shared the progress from the iPSpine project.
Read all about it:
➡️ipspine.eu/ipspine-patient-s…
🌟Volgende week dinsdag 16 april vindt het iPSpine Patiëntensymposium plaats, over het onderzoek van iPSpine naar een nieuwe therapie voor lage rugpijn.
📢Er zijn nog een paar plaatsen beschikbaar: schrijf je nog snel in via onze website! ➡️lnkd.in/e6nhcv68
#lagerugpijn
✨ Celebrating 5 Years of iPSpine Excellence! ✨ As we mark iPSpine's 5th anniversary, we stand at the precipice of the final six months, reflecting on a journey of triumphs and challenges.
Our collaborative efforts bear fruit, focusing now on concluding research activities and study analysis. Anticipating our 2024 final consortium meeting, where our dedication will shape success. Wishing you a joyful holiday season! 🌟🎄 #iPSpine #ProjectMilestone #HolidayGreetings
"Spine tester TO GO: A new, mobile testing machine for on-site flexibility measurement of motion segments“ was presented at the 18th German Spine Congress (DWG) 🥳🥳 People were very excited about the new possibilities for collaboration.
🧬 @LisanneLaagland and team reveal insights into notochordal cell-derived matrix, showing decreased inflammation and stimulation of healthy disc markers.
🌐 Dive into the groundbreaking study! 👉ipspine.eu/understanding-how…
🌟 Exciting update from iPSpine at NLSEV 2023! 🇳🇱
Josette van Maanen presented novel research on the effects of notochordal cell-derived extracellular vesicles on degenerated intervertebral disc tissue. 🧪
NLSEV: Fostering collaboration and showcasing new developments in EV research. Learn more: ipspine.eu/%f0%9f%8c%9f
@UniUtrecht @sheffielduni
#iPSpineProject #NLSEV2023 #ExtracellularVesicles #ResearchInnovation 🤝🔍
🔬 Unlocking Back Pain Mysteries: Modic Changes Explored! ipspine.eu/investigating-bac…
Chronic low back pain remains a global health challenge. Martijn Beukers and team delve into "Modic changes," potential contributors to this ailment, using dogs as a model for insights. 🐾
📊 Study Highlights:
66% of dogs exhibit Modic changes, mirroring human conditions.
Notable prevalence of Type 3 changes in dogs, a divergence from humans.
Age and disc herniation emerged as key influencers in Modic changes.
#BackPain #Research #ModicChanges #SpinalHealth🌐💊